Clinical outcomes of adjuvant treatment strategies in locally advanced gastroesophageal and gastric adenocarcinoma with poor pathological response to neoadjuvant FLOT: A Turkish Oncology Group (TOG) study.
| dc.contributor.author | Çiftçi, Atilla | |
| dc.contributor.author | Kutlu, Özlem | |
| dc.contributor.author | Canaslan, Kübra | |
| dc.contributor.author | Eroğlu, İmdat | |
| dc.contributor.author | Yıldızhan, Sezin | |
| dc.contributor.author | Aydın, Esra | |
| dc.contributor.author | Sütçüoğlu, Osman | |
| dc.date.accessioned | 2026-08-04T10:07:34Z | |
| dc.date.issued | 2026 | |
| dc.department | RTEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | |
| dc.description.abstract | ...... | |
| dc.identifier.citation | Çiftçi, A., Kutlu, Ö., Canaslan, K., Eroğlu, İ., Yıldızhan, S., Bayram, S., ... Sütcüoğlu, O. (2026). Clinical outcomes of adjuvant treatment strategies in locally advanced gastroesophageal and gastric adenocarcinoma with poor pathological response to neoadjuvant FLOT: A Turkish Oncology Group (TOG) study. Journal of Clinical Oncology, 44(16_suppl), e16150. https://doi.org/10.1200/JCO.2026.44.16_suppl.e16150 | |
| dc.identifier.doi | 10.1200/JCO.2026.44.16_suppl.e16150 | |
| dc.identifier.endpage | e16150 | |
| dc.identifier.issn | 0732-183X | |
| dc.identifier.startpage | e16150 | |
| dc.identifier.uri | https://doi.org/10.1200/JCO.2026.44.16_suppl.e16150 | |
| dc.identifier.uri | https://hdl.handle.net/11436/13336 | |
| dc.identifier.volume | 44 | |
| dc.identifier.wos | WOS:001780621300043 | |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.institutionauthor | Aydın, Esra | |
| dc.institutionauthorid | 0000-0003-0210-3153 | |
| dc.language.iso | en | |
| dc.publisher | Lippincott Williams and Wilkins | |
| dc.relation.ispartof | Journal of Clinical Oncology | |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.title | Clinical outcomes of adjuvant treatment strategies in locally advanced gastroesophageal and gastric adenocarcinoma with poor pathological response to neoadjuvant FLOT: A Turkish Oncology Group (TOG) study. | |
| dc.type | Article |











